Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
76-90 of 410
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Project Oncology®Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
John Russell, MD
Richard Wender, MD
Combatting Challenges & Health Disparities in Colorectal Cancer Care
Project Oncology®Combatting Challenges & Health Disparities in Colorectal Cancer Care
Jacob Sands, MD
Edith Mitchell, MD, MACP, FCPP, FRCP
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Project Oncology®Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Brian P. McDonough, MD, FAAFP
William Oh, MD
Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Charles Turck, PharmD, BCPS, BCCCP
Aparna R. Parikh, MD
- advertisement
Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Integrating Guideline Updates in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP
Stacey Cohen, MD
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Project Oncology®ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Charles Turck, PharmD, BCPS, BCCCP
Pooja Ghatalia, MD
Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Project Oncology®Perioperative Immunotherapy Strategies in Resectable NSCLC Care
Charles Turck, PharmD, BCPS, BCCCP
Martin Dietrich, MD, PhD
Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Project Oncology®Teledermatology Enables Earlier Diagnosis of Cutaneous Squamous Cell Carcinoma
Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Project Oncology®Smoking Status Predicts Worse Survival in Non-Melanoma Skin Cancer
Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Shared Decision-Making in Squamous Cell Carcinoma of the Anal Canal
Brian P. McDonough, MD, FAAFP
Richard Kim, MD
- advertisement
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®The Epigenetics of Lung Cancer Dormancy and Relapse
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Charles Turck, PharmD, BCPS, BCCCP
Marwan G. Fakih, MD
